Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice
Authors:
Open Access
- 19 September 2005
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (39) , 14034-14039
Abstract
Limitations of current viral-based gene therapies for malignant tumors include lack of cancer-specific targeting and insufficient tumor delivery. To ameliorate these problems and develop a truly effective adenovirus gene-based therapy for cancer, we constructed a conditionally replication competent adenovirus (CRCA) manifesting the unique properties of tumor-specific virus replication in combination with production of a cancer-selective cytotoxic cytokine, melanoma differentiation associated gene-7/interleukin-24 ( mda -7/IL-24), which embodies potent bystander antitumor activity. Cancer cell selective tropism was ensured by engineering the expression of the adenoviral E1A protein, necessary for viral replication, under the control of a minimal promoter region of progression elevated gene-3 (PEG-3), which functions selectively in diverse cancer cells with minimal activity in normal cells. In the E3 region of this CRCA, we introduced the mda -7/IL-24 gene, thereby mediating robust production of this cytokine as a function of adenovirus replication. Infection of this CRCA (designated Ad.PEG-E1A- mda -7) in normal mammary epithelial cells and breast cancer cells confirmed cancer cell selective adenoviral replication, mda -7/IL-24 expression, growth inhibition, and apoptosis induction. Injecting Ad.PEG-E1A- mda -7 into human breast cancer xenografts in athymic nude mice completely eradicated not only the primary tumor but also distant tumors (established on the opposite flank of the animal) thereby implementing a cure. This dual cancer-specific targeting strategy provides an effective approach for treating breast and other human neoplasms with the potential for eradicating both primary tumors and metastatic disease. Additionally, these studies support the potential use of mda -7/IL-24 in the therapy of malignant cancers.Keywords
This publication has 53 references indexed in Scilit:
- Potential molecular mechanism for rodent tumorigenesis: mutational generation of Progression Elevated Gene-3 (PEG-3)Oncogene, 2005
- Impact of Human Neutralizing Antibodies on Antitumor Efficacy of an Oncolytic Adenovirus in a Murine ModelClinical Cancer Research, 2004
- Tissue-specific promoters for cancer gene therapyExpert Opinion on Biological Therapy, 2004
- Immmunotherapy of cancer: from vision to standard clinical practiceJournal of Cancer Research and Clinical Oncology, 2004
- AP-1: a double-edged sword in tumorigenesisNature Reviews Cancer, 2003
- New Oncolytic Adenoviruses with Hypoxia- and Estrogen Receptor-Regulated ReplicationHuman Gene Therapy, 2002
- Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agentsCancer Cell, 2002
- Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathwaysOncogene, 2001
- A Novel, Conditionally Replicative Adenovirus for the Treatment of Breast Cancer That Allows Controlled Replication of E1a-Deleted Adenoviral VectorsHuman Gene Therapy, 2000
- Treatment of Breast CancerNew England Journal of Medicine, 1998